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Abstract
Introduction:  Management  of  pulmonary  disease  in  immunodepressed  patients  requires  a  clear
diagnostic  and  therapeutic  strategy  and  multidisciplinary  cooperation.
Discussion:  The  diagnostic  approach  should  take  into  account  the  type  of  immunodepression,
the clinical  picture,  the  radiological  signs  and  symptoms,  and  the  microbiological,  cytological
and even  histological  examination  of  the  pulmonary  or  extrapulmonary  specimens.  The  high-
resolution  CT  scan  plays  a  central  role  and  makes  it  possible  to  prioritize  the  diagnostic
possibilities.
Conclusion:  The  analysis  of  the  literature  shows  three  important  points:  the  chest  X-ray  has
low diagnostic  value;  the  CT  scan  of  the  chest  can  reveal  lesions  that  cannot  be  detected  on
a standard  chest  X-ray;  the  CT  scan  is  helpful  for  early  detection  and  monitoring  of  invasive
pulmonary aspergillosis.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
The  pulmonary  diseases  that  occur  in  immunodepressed  patients  are  common  and  serious.
Their  etiologies  are  numerous  and  may  be  infectious  or  noninfectious.  Their  management
requires  standardized  pulmonary  and  immunohematological  testing  in  order  to  suggest  an
appropriate  choice  of  diagnostic  tests  and  treatments.  Multidisciplinary  cooperation  among
pulmonologists,  infectious  disease  specialists,  oncologists,  hematologists,  radiologists,
microbiologists,  and  intensivists  is  preferable.  Such  an  organization  is  essential,  since
any  diagnostic  delay  worsens  the  prognosis,  which  is  dependent  on  the  severity  of  the
pulmonary  disease  itself,  but  also  on  the  immunodepression  and  underlying  comorbidities.
∗ Corresponding author.
E-mail address: c.godet@chu-poitiers.fr (C. Godet).
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with  no  primary  infection  when  the  donor  is  seroposi-26  
The  diagnostic  process  involves  several  factors:
the  type,  duration,  and  degree  of  underlying  immunode-
pression,  which  determines  the  microbiological  possibili-
ties  to  consider;
the  interview  and  clinical  examination  (nonspeciﬁc);
the  analysis  of  signs  and  symptoms  on  the  standard  chest
X-ray  (CXR)  and  especially  the  high-resolution  CT  scan
(HR-CT),  which  makes  it  possible  to  determine  the  eti-
ological  possibilities;
the  results  of  microbiological  or  histological  examina-
tions,  which  sometimes  make  it  possible  to  conﬁrm  the
diagnosis.
ifferent types of immunodepression and
rincipal etiologies of pulmonary
onditions
mmunodepression  is  the  result  of  a  medical  condition  or
reatment  that  impairs  the  body’s  defense  mechanisms
or  ﬁghting  infections.  We  can  schematically  deﬁne  three
ajor  types  of  immunodepression:  neutropenic  patients,
IV-infected  patients,  and  other  types  of  immunodepressed
atients.
eutropenic patients
eutropenia  is  an  immune  deﬁciency  essentially
nvolving  phagocytosis.  Profound  neutropenia  is  deﬁned
s  a  decrease  in  the  neutrophil  count  to  less  than
00/mm3.
During  the  initial  phase  of  neutropenia,  the  causal
athogens  are  mainly  bacteria  of  the  Gram-positive  cocci
ype,  particularly  Staphylococcus  aureus,  or  Gram-negative
acteria  such  as  Pseudomonas  aeruginosa. When  neutrope-
ia  lasts  more  than  5—7  days,  fungal  infections  may  occur
aspergillosis,  candidiasis,  mucormycosis).  If  there  is  a  his-
ory  of  aspergillosis,  it  may  occur  earlier.  From  a  radiological
erspective,  these  patients  have  a  particular  presenta-
ion,  since  there  may  be  an  actual  bacterial  infection
ith  no  parenchymal  opacity,  which  may  not  manifest  until
he  neutropenia  is  corrected.  Conversely,  fungal  infections
anifest  radiologically,  since  contrary  to  bacterial  infec-
ions,  the  radiological  image  does  not  correspond  to  an
nﬂammatory  reaction  associated  with  the  infection,  but
o  invasion  of  the  pulmonary  parenchyma  by  aspergillar
yphae  (for  example)  and  areas  of  infarction  due  to  pul-
onary  vascular  invasion.  This  pathogenesis  explains  the
odular  or  triangular  (focal)  nature  of  the  opacity  or  radi-
logical  image  at  this  stage,  said  image  being  most  often
urrounded  by  a  halo  of  ground  glass  attenuation  on  the
T  scan,  indicating  the  hemorrhagic  nature  of  the  nodule.
urthermore,  it  is  important  to  know  that,  while  infectious
ulmonary  complications  predominate  during  the  aplas-
ic  phase,  pulmonary  opacities  should  also  suggest  other
roblems  such  as  intraalveolar  hemorrhages,  hydrostatic
r  lesional  pulmonary  edema,  and  causes  related  to  drug
oxicity.
This  is  a  major  diagnostic  challenge,  since  prognosis
irectly  correlates  with  how  quickly  the  underlying  pul-
onary  condition  is  treated.
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IV-infected patients
ere,  the  immune  deﬁciency  is  essentially  linked  to  a
uantitative  and  functional  CD4  T-cell  deﬁciency.  Even
hough  triple  antiretroviral  therapy  has  decreased  the  num-
er  of  opportunistic  infections  that  deﬁne  onset  of  the
IDS  stage,  such  complications  are  still  common  in  undiag-
osed  patients  and  those  in  therapeutic  failure.  Infectious
nd  noninfectious  pulmonary  complications  in  HIV  patients
orrelate  with  CD4  T-cell  levels.  Pneumocystosis  is  the
ost  common  infectious  complication  in  patients  with
enerally  fewer  than  200  CD4  T-cells/mm3. Tuberculosis
ccurs  earlier  in  the  course  of  HIV  infection  in  patients
ith  a  higher  CD4  T-cell  level.  Some  emergent  noninfec-
ious  pulmonary  diseases  have  become  important  to  know
ince  the  introduction  of  antiretroviral  therapies:  immune
estoration  syndrome,  tumor  conditions  (Kaposi’s  sarcoma,
ggressive  lymphoid  proliferation,  lung  cancer,  etc.),  dif-
use  inﬁltrative  disease  (lymphoid  interstitial  pneumonia,
rganizing  pneumonia,  smoking-related  diffuse  inﬁltrative
neumonia,  pulmonary  drug  toxicity,  etc.)  or  even  cardio-
ascular  complications.  The  HR-CT  appears  to  be  a  beneﬁcial
ool  for  the  differential  diagnosis  of  these  pulmonary
omplications,  since  the  analysis  of  signs  and  symptoms
onsiderably  reduces  the  number  of  diagnostic  possibilities,
uides  the  choice  of  endoscopic  and  biopsy  specimens  to
ake,  and  makes  it  possible  to  subsequently  assess  treatment
esponse.
one marrow graft patients
ome  patients  who  have  undergone  total  body  radia-
ion  resemble  asplenic  patients  and  are  very  vulnerable
o  pneumococcal  infections.  During  conditioning,  we  ﬁnd
hat  the  risks  related  to  chemo-induced  neutropenia
re  often  prolonged;  in  particular,  the  risk  of  inva-
ive  pulmonary  aspergillosis  is  especially  high.  Then,
uring  bone  marrow  aplasia,  these  patients  are  particu-
arly  susceptible  to  cytomegalovirus  (CMV)  infections  and
ycoses  such  as  pneumocystosis.  Later,  in  cases  of  graft-
ersus-host  (GVH)  disease,  noninfectious  diseases  such  as
ronchiolitis  obliterans,  organizing  pneumonia,  interstitial
ung  disease,  or  pulmonary  cytolytic  thrombi  should  be
onsidered.
rgan transplant patients
hese  patients  have  complications  associated  with  cellular
mmune  deﬁciency  induced  by  immunosuppressant  therapy.
hey  are  particularly  susceptible  to  intracellular  pathogens
uch  as  Legionella  pneumophila,  Mycobacterium  tubercu-
osis  and  Nocardia  asteroides. Aspergillus  and  Nocardia
nfections  represent  two-thirds  of  the  causes  of  infection
n  heart  transplant  patients.  Of  note  is  the  high  risk  of
MV  infection  in  lung  transplant  patients  and  of  toxoplas-
osis  in  heart  transplant  patients,  particularly  in  patientsive.  Furthermore,  as  in  bone  marrow  graft  patients  and
VH,  noninfectious  entities  such  as  bronchiolitis  obliterans,
rganizing  pneumonia,  and  interstitial  lung  disease  may
anifest.
e  im
b
t
s
l
M
W
t
b
p
u
i
c
i
d
t
d
n
b
i
r
t
S
i
[
a
e
[
a
i
a
s
H
i
n
r
R
S
T
s
i
a
e
l
m
a
d
s
a
C
n
aBeneﬁt  of  CT  scanning  for  assessing  pulmonary  disease  in  th
Patients receiving high doses of
corticosteroids
They  have  a  granulocyte  function  deﬁciency  essentially  due
to  chemotaxis,  but  also  a  decrease  in  cytokine  produc-
tion  and  inhibition  of  T-cell  activation.  These  patients  are
particularly  susceptible  to  the  risk  of  pneumocystosis,  and
frequent  differential  diagnosis  problems  versus  a  speciﬁc
underlying  condition  in  the  context  of  collagen  disease,  lym-
phoproliferative  syndromes,  and  solid  tumors  treated  with
chemotherapy.  We  compare  them  with  patients  treated  with
other  immunosuppressants.
Diagnostic approach
The  diagnostic  approach  should  take  several  factors  into
account:
• the  diathesis  and  underlying  immunodepression,  since  the
possibilities  are  different  depending  on  type  and  duration;
• the  clinical  workup,  which  is  necessary  but  nonspeciﬁc,
and  must  determine  the  onset  circumstances  and  nature
of  the  respiratory  symptoms  as  well  as  the  associated
signs;
• the  radiologic  signs  and  symptoms,  where  the  HRCT  scan
plays  a  central  role  and  makes  it  possible  to  prioritize  the
diagnostic  possibilities  based  on  the  pattern  or  predomi-
nant  semiotic  component;
• the  microbiological,  cytological,  or  even  histological
examinations  of  pulmonary  or  extrapulmonary  specimens,
which  sometimes  make  it  possible  to  conﬁrm  the  diagno-
sis.
Anamnesis
The  nature  of  the  underlying  disease,  the  immunosuppres-
sants  taken,  and  the  foreseeable  duration  and  profoundness
of  the  neutropenia  are  all  fundamental  elements  in  the
infectious  risk  assessment.  One  of  the  objectives  is  to  draw
up  the  patient’s  immunosuppression  proﬁle  in  order  to  assess
the  pulmonary  infection  risks.  Furthermore,  it  is  important
to  thoroughly  evaluate  the  chronology  of  the  events,  i.e.,
duration  of  the  immunodepression  and  other  potentially
toxic  therapies  received  (chemotherapy,  radiation  therapy,
immunotherapy,  immunosuppressant  therapies,  etc.).  The
stage  of  the  underlying  disease  must  be  known,  along  with
its  complications,  in  order  to  prioritize  the  differential  diag-
noses.  Examining  the  patient’s  lifestyle  (trips  abroad,  work
and  recreational  activities,  etc.)  makes  it  possible  to  detect
exposure  to  certain  particular  risks.  Lastly,  the  nature  and
effect  of  anti-infective  treatments  received  at  the  time  of
diagnosis  of  pneumonia,  whether  empirical,  preemptive,
or  prophylactic,  must  be  known,  because  they  help  guide
the  diagnostic  approach  and  limit  the  number  of  possibili-
ties.
Clinical presentationThe  clinical  examination  is  essential  but  nonspeciﬁc.  Apart
from  fever,  respiratory  signs  most  often  have  little  value  in
determining  a  cause  of  infection.  The  existence  of  extratho-
racic  signs  can  have  great  diagnostic  value  (pulmonary  and
T
I
pmunodepressed  patient  427
rain  involvement  in  a  seropositive  patient  could  suggest
oxoplasmosis  or  cryptococcosis,  for  example).  In  addition,
uch  extrathoracic  locations  may  make  it  possible  to  take
ess  invasive  diagnostic  specimens.
icrobiological diagnostic tests
hether  or  not  they  are  invasive,  the  beneﬁt  of  a  diagnostic
ool  should  be  assessed  on  a  case-by-case  basis:  expected
eneﬁt  versus  beneﬁt;  impact  of  expected  results  on  the
atient’s  prognosis  and  choice  of  therapy.  A  sputum  test  is
seful  for  detecting  bacteria,  mycobacteria,  and  fungi.  The
nduced  sputum  test  is  important  for  diagnosing  pneumo-
ystosis  in  patients  who  are  seropositive  for  HIV.  However,
n  some  cases  (mycobacteria  or  mold),  it  is  difﬁcult  to
istinguish  between  simple  colonization  and  an  actual  infec-
ion.
The  nasopharyngeal  aspiration  is  cost-effective  for
iagnosing  respiratory  viral  infections  (molecular  tech-
iques)  [1].  Detection  of  galactomannan  in  the  serum  or
ronchoalveolar  lavage  (BAL)  is  very  useful  in  diagnos-
ng  invasive  pulmonary  aspergillosis  (IPA).  However,  the
esults  reported  by  Weisser  in  107  patients  with  IPA  show
hat  a  CT  scan  provides  an  even  earlier  diagnosis  [2].
erological  tests  are  also  more  likely  to  be  positive  in  angio-
nvasive  forms  (80%)  than  in  broncho-invasive  forms  (60%)
3].
Bronchoscopy,  which  is  contraindicated  in  patients  in
cute  respiratory  failure,  remains  the  gold  standard  for
xploring  pulmonary  disease  in  immunodepressed  patients
4].  That  test  makes  it  possible  to  perform  guided  BAL,  but
lso  bronchial  and  transbronchial  biopsies,  which  improve
ts  diagnostic  performance  [5].  Pulmonary  biopsies  can
lso  be  performed  by  transthoracically,  guided  by  CT
can,  and  surgically  (video-assisted  or  open  chest  surgery).
ere  too,  the  use  of  these  diagnostic  techniques  in  such
mmunodepressed  and  sometimes  severely  thrombopenic  or
eutropenic  patients  requires  an  assessment  of  the  expected
isk/beneﬁt  ratio  [6].
ole of imaging
tandard  chest  X-ray
his  is  the  ﬁrst  test  required  for  immunodepressed  patients
uspected  of  having  lung  disease.  It  is  helpful  for  detecting
ntrathoracic  abnormalities,  but  it  is  difﬁcult  to  interpret
nd  its  sensitivity  is  limited,  as  is  its  ability  to  determine  an
tiology.  In  a series  of  autopsies  in  45  leukemia  patients  with
ung  involvement,  CXR  seemed  helpful  for  diagnosing  pul-
onary  abnormalities  but  very  inadequate  for  establishing
n  etiological  diagnosis,  except  in  cases  of  acute  respiratory
istress  syndrome  and  pulmonary  hemorrhage  [7].  In  another
eries  of  immunodepressed  patients  not  infected  with  HIV,
 correct  diagnosis  was  made  based  on  an  analysis  of  the
XR  alone  in  34%  of  cases  [8].  The  CXR  was  reported  to  be
ormal  in  6%  of  HIV-infected  patients  with  an  infection  such
s  pneumocystosis  [9].he  CT  scan  of  the  chest
t  can  play  an  important  role  in  the  management  of
ersistent  fever  in  immunodepressed  patients.  The  two
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opulations  in  which  the  differential  diagnostic  aid  provided
y  a  CT  scan  has  been  studied  the  most  are  HIV-infected
nd  neutropenic  patients.  In  HIV-infected  patients,  the
RCT  is  often  essential  for  conﬁrming  or  ruling  out  a
ulmonary  condition  and  sometimes  provides  etiological
uidance  [10—16].
In  patients  with  febrile  neutropenia,  the  HRCT  is  help-
ul  for  assessing  a  lung  condition  when  the  CXR  is  normal
r  subnormal.  In  that  case,  it  helps  determine  the  eti-
logy  and  guide  the  collection  of  specimens  such  as  BAL
17,18].  A  study  of  87  neutropenic  patients  with  fever  last-
ng  more  than  2  days  while  on  broad-spectrum  antibiotic
herapy  showed  that  more  than  half  of  the  patients  with
 normal  CXR  had  abnormalities  suggestive  of  pneumo-
ia  on  the  HRCT  [19]. Another  series  of  112  neutropenic
atients  with  a  persistent  fever  and  normal  CXR  reported
hat  the  CT  scan  detected  pneumonia  in  60%  of  them  [20].
n  these  two  studies,  the  CT  signs  suggestive  of  pneumo-
ia  preceded  CXR  abnormalities  by  an  average  of  5  days.
he  authors  concluded  that  any  neutropenic  patient  with  a
esistant  fever  after  48—72  hours  of  broad-spectrum  antibi-
tic  therapy and  a  normal  CXR  should  have  a  CT  scan  of  the
hest.  In  another  study  of  33  patients  with  febrile  neutrope-
ia  in  whom  the  CXR  was  interpreted  as  normal  or  subnormal
n  one-third  and  two-thirds  of  the  cases,  respectively,  the
T  scan  resulted  in  a  treatment  change  in  one-third  of  the
atients  [21].
In neutropenic  patients  with  IPA,  even  a  repeated  CXR
as  low  sensitivity  and  low  speciﬁcity.  When  the  CT  scan
hows  nodular  opacities  (and  especially  if  those  nodules
re  surrounded  by  a  halo  of  ground  glass  attenuation  or
‘halo  sign’’),  an  infection  of  fungal  etiology  (most  often
spergillar)  should  be  suspected  [22]. During  the  correction
f  neutropenia  phase,  alveolar  condensation  with  central
ypodense  area  or  presence  of  a  nodule  with  an  ‘‘air  cres-
ent’’  appearance  are  suggestive  of  IPA.  If  the  CT  scan  is
ormal,  an  extrapulmonary  etiology  of  the  fever  must  be
ought  [22]. The  high  incidence  of  IPA  and  high  morbidity  and
ortality  from  this  disease  in  febrile  neutropenia  patients
ave  led  to  numerous  studies  on  the  role  of  the  CT  scan  in
he  early  diagnosis  of  IPA  [23—25].
Several  studies  suggest  that  early  routine  use  of  the
T  scan  in  neutropenic  patients  provides  a  much  earlier
iagnosis  of  aspergillar  infection  [26,27].  In  one  of  those
tudies,  the  time  to  diagnosis  was  reduced  to  2—7  days
27]. Early  diagnosis  and  aggressive  management  greatly
etermine  the  prognosis  in  these  patients  [23—28]. The
pproach  combining early  CT  scan  and  detection  of  circu-
ating  galactomannan  is  probably  the  most  successful  [29].
urthermore,  contrast  injection  makes  it  possible  to  clarify
he  relationships  between  lesions  and  vascular  structures
assessment  of  risk  of  hemoptysis),  guide  any  diagnostic
ransparietal  puncture  biopsy,  monitor  changes  in  images
uring  speciﬁc  treatment,  and  take  an  inventory  of  resid-
al  lesions  for  purposes  of  potential  ‘‘cleanup  surgery’’.
he  HRCT  also  beneﬁts  other  immunodepressed  patients.
ulati  assessed  the  diagnostic  contribution  of  the  HRCT  in
1  kidney  transplant  patients  suspected  of  having  pulmonary
nfections;  compared  with  a  CXR,  the  CT  scan  rectiﬁed  the
tiological  diagnosis  in  11  patients  (50%)  [30].
The  HRCT  also  clariﬁed  the  etiology  of  pulmonary
omplications  in  febrile  patients  who  received  aC.  Godet  et  al.
ematopoietic  stem  cell  transplant  (HSCT).  One  team
howed  the  CT  scans  were  abnormal  at  least  one  week
head  of  positive  serological  tests  in  these  patients  [31].
The  possibility  of  noninfectious  pulmonary  complications
hould  be  borne  in  mind.  These  include  speciﬁc  conditions
elated  to  the  underlying  disease,  drug-  or  radiation-induced
oxicity,  intraalveolar  hemorrhaging,  and  hydrostatic  pul-
onary  edema.  The  CT  scan  also  makes  it  possible  to  suggest
uch  complications  when  there  is  a  nonspeciﬁc  clinical  pre-
entation.  Similarly,  the  HRCT  is  of  major  beneﬁt  for  early
iagnosis  of  the  late  noninfectious  pulmonary  complications
hat  often  mark  the  follow-up  of  HSCT  patients  and  are
ften  related  to  GVH  disease.  Recently,  the  HRCT  proved
ts  beneﬁt  for  early  screening  of  bronchiolar  involvement
n  various  diseases  such  as  bronchiolitis  obliterans  after
ung  transplantation,  before  the  onset  of  clinical  or  func-
ional  respiratory  effects  [32—36]. In  fact,  the  CXR  is  most
ften  initially  normal  and  may  remain  so  during  the  pro-
ression  of  bronchiolitis  obliterans.  The  CT  scan  makes
t  possible  to  do  a  morphological  analysis  of  the  bronchi
nd  bronchioli  (dilatation,  parietal  thickness,  etc.)  and
o  screen  for  incipient  bronchiolar  involvement  by  show-
ng  air  trapping  during  forced  exhalation  [34—40]. But
ir  trapping  during  exhalation  may  also  be  due  to  other
onditions,  given  the  difﬁcult  medical  history  of  HSCT
atients  (radiation  therapy,  chemotherapy,  infection,  etc.)
41,42].
onclusion
anagement  of  pulmonary  disease  in  immunodepressed
atients  requires  a  formal  analysis  to  establish  the  best
iagnostic  and  therapeutic  strategy  and  requires  multidisci-
linary  cooperation.  The  initial  diagnostic  approach  should
ake  into  account  the  diathesis  and  underlying  immunode-
ression,  the  clinical  examination,  and  the  radiological  signs
nd  symptoms.  Imaging,  and  especially  the  HRCT,  plays  a
entral  management  role,  making  it  possible  to  prioritize  the
iagnostic  possibilities  based  on  the  predominant  pattern.
icrobiological,  cytological,  and  histological  examinations
f  pulmonary  or  extrapulmonary  specimens  then  sometimes
ake  it  possible  to  conﬁrm  the  diagnosis.
TAKE-HOME  MESSAGES
• Management  of  pulmonary  disease  in  immuno-
depressed  patients  requires  a  clear  diagnostic
and  therapeutic  strategy  and  multidisciplinary
cooperation.
• The  diagnostic  approach  should  take  into  account
the  type  of  immunodepression,  the  clinical  picture,
the  radiological  signs  and  symptoms,  and  the
examination  of  the  pulmonary  or  extrapulmonary
specimens.
• The  high-resolution  CT  scan  makes  it  possible  to
prioritize  the  diagnostic  possibilities  and  allows
early  detection  of  conditions  that  are  not  visible
on  the  chest  X-ray,  such  as  invasive  pulmonary
aspergillosis.
e  im
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[Beneﬁt  of  CT  scanning  for  assessing  pulmonary  disease  in  th
• Any  neutropenic  patient  with  a  resistant  fever  after
48—72  hours  of  broad-spectrum  antibiotic  therapy
and  a  normal  chest  X-ray  should  have  a  CT  scan  of
the  chest.
• The  injection  of  contrast  clariﬁes  the  relationships
between  lesions  and  vascular  structures  (assessment
of  risk  of  hemoptysis).
• Pulmonary  opacities  in  immunodepressed  patients
should  suggest  noninfectious  diseases  such  as
intraalveolar  hemorrhages,  hydrostatic  or  lesional
pulmonary  edema,  and  causes  related  to  drug
toxicity  or  conditions  related  to  the  underlying
disease  (tumors,  systemic  diseases,  etc.).
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